Menten AI
Latest round
- Seed
Last raised
- Jun 2020
Total raised
- $4.2M
Investors
- 3
About Menten AI
Menten AI, Inc.Founded in 2018 in San Francisco, US, Menten AI, Inc. focuses on advancing drug discovery through its AI platform for peptide therapeutics. The founders, Hans Melo and Tamás Görbe, have experience in technology and biotech sectors.Menten AI's primary offering is a generative AI platform specifically designed for the development of peptide therapeutics. The platform utilizes machine learning techniques combined with first-principles physics-based molecular modeling to address the significant challenges associated with traditional drug design, such as small datasets and computational limitations. By generating its own data, the platform enables the design and optimization of novel peptides that exhibit desirable drug-like properties, including nanomolar potency, high plasma stability, cell permeability, and oral bioavailability. Targeting currently undruggable and hard-to-drug targets, Menten AI’s solutions serve a diverse client base that includes pharmaceutical companies and biotech firms engaged in drug discovery.Menten AI’s revenue model is structured around partnerships with pharmaceutical and biotechnology companies, primarily operating on a B2B basis. The company engages clients through collaborative agreements that enable the use of its AI-driven platform for drug discovery, with potential transactions encompassing milestone payments based on clinical success and licensing fees associated with the commercialization of peptide therapeutics. The platform's flagship service focuses on delivering drug-like hit molecules within an expedited timeframe of eight weeks, significantly faster than traditional methods. As a result, clients benefit from reduced development cycles, allowing for quicker entry into the market with novel therapeutics. The company aims to expand its market presence in Europe and Asia by 2024, with initiatives to establish partnerships with local biotech firms.
Who invested in Menten AI
3 investors across 2 rounds
See all investors in Menten AI
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Menten AI
Who invested in Menten AI?
Menten AI has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Menten AI raised?
Menten AI has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Menten AI last raise money?
Menten AI's most recent round on record is a Seed, in Jun 2020.
What does Menten AI do?
Menten AI is a biotechnology company.
Where is Menten AI headquartered?
Menten AI is headquartered in San Francisco, US.
Which VCs invest in companies like Menten AI?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Menten AI's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Menten AI? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.